No Data
HAITONG INT'L: Bullish on the bottom reversal of the Traditional Chinese Medicine Industry, with the State-owned Enterprise Reform and mergers and acquisitions resonating in development.
As aging continues to intensify, the demand in the Silver economy and chronic disease medication-related fields is viewed as Bullish.
Mayinglong Pharmaceutical Group's MYL Ointment Gets Regulatory Approval for Clinical Trials
Mayinglong Pharmaceutical Group (600993.SH): MYL ointment (Musk Hemostatic Analgesic Ointment, tentative) approved for clinical trials.
Mayinglong Pharmaceutical Group (600993.SH) has announced that recently, the company received approval from the National Medical Products Administration for...
Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged CN¥664m Last Week
There Is A Reason Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Undemanding
Ma Yinglong Report for the Third Quarter of 2024
Mayinglong Pharmaceutical Group (SHSE:600993) Jumps 4.1% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
